1. A contrast in safety, pharmacokinetics and pharmacodynamics across age groups after a single 50 mg oral dose of the γ‐secretase inhibitor avagacestat. (14th December 2012) Authors: Tong, Gary; Wang, Jun‐Sheng; Sverdlov, Oleksandr; Huang, Shu‐Pang; Slemmon, Randy; Croop, Robert; Castaneda, Lorna; Gu, Huidong; Wong, Oi; Li, Hewei; Berman, Robert M.; Smith, Christina; Albright, Charles F.; Dockens, Randy Journal: British journal of clinical pharmacology Issue: Volume 75:Number 1(2013:Jan.) Page Start: 136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A contrast in safety, pharmacokinetics and pharmacodynamics across age groups after a single 50 mg oral dose of the γ‐secretase inhibitor avagacestat. (14th December 2012) Authors: Tong, Gary; Wang, Jun‐Sheng; Sverdlov, Oleksandr; Huang, Shu‐Pang; Slemmon, Randy; Croop, Robert; Castaneda, Lorna; Gu, Huidong; Wong, Oi; Li, Hewei; Berman, Robert M.; Smith, Christina; Albright, Charles F.; Dockens, Randy Journal: British journal of clinical pharmacology Issue: Volume 75:Number 1(2013:Jan.) Page Start: 136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗